<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Paulson, Daryl S.</style></author></authors><secondary-authors></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Some Basic Points Concerning Meta-Analysis</style></title><secondary-title><style face="normal" font="default" size="100%">American Society for Clinical Laboratory Science</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2013</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2013-01-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">30-38</style></pages><doi><style  face="normal" font="default" size="100%">10.29074/ascls.26.1.30</style></doi><volume><style face="normal" font="default" size="100%">26</style></volume><issue><style face="normal" font="default" size="100%">1</style></issue><abstract><style  face="normal" font="default" size="100%">Multiple studies have been performed on a variety of substances, often producing contradictory results. Meta-analysis has provided a means of evaluating these disparate results, combining them into a summary statistic. Using continuous data for baseline and one sample point, several studies were evaluated to achieve a single result, demonstrating the meta-analysis evaluation process.ABBREVIATIONS: ANOVA-analysis of variance, H0-null hypothesis, HA-alternative hypothesis, FDA-Food and Drug Administration.</style></abstract></record></records></xml>